[an error occurred while processing this directive]

Shantha Biotech introduces DTPH combination vaccine
Glenmark’s Oglemilast gets FDA approval for clinical trial

‘Activated recombinant factor VII acts like a targeted missile’
Professor Uri Martinowitz, the Chief Advisor to the Israeli defense forces in the field of hemorrhage control, and he is a member of the Israeli defense force trauma advisory board. He has acted as a consultant and received research support and honoraria from Novo Nordisk Pharmaceuticals. Dr Martinowitz speaks to Sapna Dogra about NovoSeven, its development and advantages.